| UniProt ID | IASPP_HUMAN | |
|---|---|---|
| UniProt AC | Q8WUF5 | |
| Protein Name | RelA-associated inhibitor | |
| Gene Name | PPP1R13L | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 828 | |
| Subcellular Localization | Cytoplasm . Nucleus . Predominantly cytoplasmic but also nuclear. | |
| Protein Description | Regulator that plays a central role in regulation of apoptosis and transcription via its interaction with NF-kappa-B and p53/TP53 proteins. Blocks transcription of HIV-1 virus by inhibiting the action of both NF-kappa-B and SP1. Also inhibits p53/TP53 function, possibly by preventing the association between p53/TP53 and ASPP1 or ASPP2, and therefore suppressing the subsequent activation of apoptosis.. | |
| Protein Sequence | MDSEAFQSARDFLDMNFQSLAMKHMDLKQMELDTAAAKVDELTKQLESLWSDSPAPPGPQAGPPSRPPRYSSSSIPEPFGSRGSPRKAATDGADTPFGRSESAPTLHPYSPLSPKGRPSSPRTPLYLQPDAYGSLDRATSPRPRAFDGAGSSLGRAPSPRPGPGPLRQQGPPTPFDFLGRAGSPRGSPLAEGPQAFFPERGPSPRPPATAYDAPASAFGSSLLGSGGSAFAPPLRAQDDLTLRRRPPKAWNESDLDVAYEKKPSQTASYERLDVFARPASPSLQLLPWRESSLDGLGGTGKDNLTSATLPRNYKVSPLASDRRSDAGSYRRSLGSAGPSGTLPRSWQPVSRIPMPPSSPQPRGAPRQRPIPLSMIFKLQNAFWEHGASRAMLPGSPLFTRAPPPKLQPQPQPQPQPQSQPQPQLPPQPQTQPQTPTPAPQHPQQTWPPVNEGPPKPPTELEPEPEIEGLLTPVLEAGDVDEGPVARPLSPTRLQPALPPEAQSVPELEEVARVLAEIPRPLKRRGSMEQAPAVALPPTHKKQYQQIISRLFHRHGGPGPGGPEPELSPITEGSEARAGPPAPAPPAPIPPPAPSQSSPPEQPQSMEMRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALHGQEGYVPRNYFGLFPRVKPQRSKV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDSEAFQS -------CCHHHHHH | 13.28 | 22814378 | |
| 19 | Phosphorylation | FLDMNFQSLAMKHMD HHHHHHHHHHHHHCC | 17.60 | 28555341 | |
| 28 | Ubiquitination | AMKHMDLKQMELDTA HHHHCCHHHHHHHHH | 43.25 | - | |
| 43 | Phosphorylation | AAKVDELTKQLESLW HHHHHHHHHHHHHHH | 18.07 | 24719451 | |
| 48 | Phosphorylation | ELTKQLESLWSDSPA HHHHHHHHHHCCCCC | 43.67 | 24719451 | |
| 51 | Phosphorylation | KQLESLWSDSPAPPG HHHHHHHCCCCCCCC | 33.24 | 22199227 | |
| 53 | Phosphorylation | LESLWSDSPAPPGPQ HHHHHCCCCCCCCCC | 19.90 | 22199227 | |
| 65 | Phosphorylation | GPQAGPPSRPPRYSS CCCCCCCCCCCCCCC | 61.63 | 24719451 | |
| 70 | Phosphorylation | PPSRPPRYSSSSIPE CCCCCCCCCCCCCCC | 20.76 | 28985074 | |
| 71 | Phosphorylation | PSRPPRYSSSSIPEP CCCCCCCCCCCCCCC | 25.64 | 25159151 | |
| 72 | Phosphorylation | SRPPRYSSSSIPEPF CCCCCCCCCCCCCCC | 21.12 | 30278072 | |
| 73 | Phosphorylation | RPPRYSSSSIPEPFG CCCCCCCCCCCCCCC | 26.75 | 30278072 | |
| 74 | Phosphorylation | PPRYSSSSIPEPFGS CCCCCCCCCCCCCCC | 44.07 | 30278072 | |
| 81 | Phosphorylation | SIPEPFGSRGSPRKA CCCCCCCCCCCCCCC | 33.57 | 22167270 | |
| 82 | Methylation | IPEPFGSRGSPRKAA CCCCCCCCCCCCCCC | 50.41 | 54558243 | |
| 84 | Phosphorylation | EPFGSRGSPRKAATD CCCCCCCCCCCCCCC | 22.03 | 22167270 | |
| 87 | Methylation | GSRGSPRKAATDGAD CCCCCCCCCCCCCCC | 45.84 | 116253281 | |
| 87 | Ubiquitination | GSRGSPRKAATDGAD CCCCCCCCCCCCCCC | 45.84 | - | |
| 90 | Phosphorylation | GSPRKAATDGADTPF CCCCCCCCCCCCCCC | 39.56 | 22199227 | |
| 95 | Phosphorylation | AATDGADTPFGRSES CCCCCCCCCCCCCCC | 21.71 | 21815630 | |
| 100 | Phosphorylation | ADTPFGRSESAPTLH CCCCCCCCCCCCCCC | 35.96 | 21945579 | |
| 102 | Phosphorylation | TPFGRSESAPTLHPY CCCCCCCCCCCCCCC | 40.57 | 25159151 | |
| 105 | Phosphorylation | GRSESAPTLHPYSPL CCCCCCCCCCCCCCC | 37.10 | 21945579 | |
| 109 | Phosphorylation | SAPTLHPYSPLSPKG CCCCCCCCCCCCCCC | 16.51 | 21945579 | |
| 110 | Phosphorylation | APTLHPYSPLSPKGR CCCCCCCCCCCCCCC | 24.66 | 22167270 | |
| 113 | Phosphorylation | LHPYSPLSPKGRPSS CCCCCCCCCCCCCCC | 28.13 | 25159151 | |
| 117 | Methylation | SPLSPKGRPSSPRTP CCCCCCCCCCCCCCC | 33.77 | 115488459 | |
| 119 | Phosphorylation | LSPKGRPSSPRTPLY CCCCCCCCCCCCCCC | 52.17 | 23927012 | |
| 120 | Phosphorylation | SPKGRPSSPRTPLYL CCCCCCCCCCCCCCC | 22.53 | 25159151 | |
| 122 | Dimethylation | KGRPSSPRTPLYLQP CCCCCCCCCCCCCCC | 51.42 | - | |
| 122 | Methylation | KGRPSSPRTPLYLQP CCCCCCCCCCCCCCC | 51.42 | 54558235 | |
| 123 | Phosphorylation | GRPSSPRTPLYLQPD CCCCCCCCCCCCCCC | 22.49 | 21945579 | |
| 126 | Phosphorylation | SSPRTPLYLQPDAYG CCCCCCCCCCCCCCC | 12.42 | 21945579 | |
| 132 | Phosphorylation | LYLQPDAYGSLDRAT CCCCCCCCCCCCCCC | 18.03 | 21945579 | |
| 134 | Phosphorylation | LQPDAYGSLDRATSP CCCCCCCCCCCCCCC | 17.89 | 22167270 | |
| 137 | Methylation | DAYGSLDRATSPRPR CCCCCCCCCCCCCCC | 45.09 | 58859091 | |
| 139 | Phosphorylation | YGSLDRATSPRPRAF CCCCCCCCCCCCCCC | 39.91 | 30576142 | |
| 140 | Phosphorylation | GSLDRATSPRPRAFD CCCCCCCCCCCCCCC | 20.23 | 30576142 | |
| 142 | Methylation | LDRATSPRPRAFDGA CCCCCCCCCCCCCCC | 32.86 | 58859107 | |
| 144 | Methylation | RATSPRPRAFDGAGS CCCCCCCCCCCCCCC | 49.52 | 58859131 | |
| 151 | Phosphorylation | RAFDGAGSSLGRAPS CCCCCCCCCCCCCCC | 23.12 | 20873877 | |
| 152 | Phosphorylation | AFDGAGSSLGRAPSP CCCCCCCCCCCCCCC | 33.65 | 21712546 | |
| 155 | Dimethylation | GAGSSLGRAPSPRPG CCCCCCCCCCCCCCC | 48.93 | - | |
| 155 | Methylation | GAGSSLGRAPSPRPG CCCCCCCCCCCCCCC | 48.93 | 54558251 | |
| 158 | Phosphorylation | SSLGRAPSPRPGPGP CCCCCCCCCCCCCCC | 32.34 | 25159151 | |
| 160 | Methylation | LGRAPSPRPGPGPLR CCCCCCCCCCCCCCH | 53.82 | 54558267 | |
| 167 | Dimethylation | RPGPGPLRQQGPPTP CCCCCCCHHCCCCCC | 29.88 | - | |
| 167 | Methylation | RPGPGPLRQQGPPTP CCCCCCCHHCCCCCC | 29.88 | 24129315 | |
| 173 | Phosphorylation | LRQQGPPTPFDFLGR CHHCCCCCCCCCCCC | 39.46 | 28188228 | |
| 180 | Methylation | TPFDFLGRAGSPRGS CCCCCCCCCCCCCCC | 37.61 | 24129315 | |
| 183 | Phosphorylation | DFLGRAGSPRGSPLA CCCCCCCCCCCCCCC | 15.50 | 22167270 | |
| 185 | Methylation | LGRAGSPRGSPLAEG CCCCCCCCCCCCCCC | 60.98 | 54558259 | |
| 187 | Phosphorylation | RAGSPRGSPLAEGPQ CCCCCCCCCCCCCCC | 20.30 | 22167270 | |
| 200 | Methylation | PQAFFPERGPSPRPP CCCCCCCCCCCCCCC | 63.66 | 58854889 | |
| 203 | Phosphorylation | FFPERGPSPRPPATA CCCCCCCCCCCCCCC | 36.04 | 25159151 | |
| 205 | Methylation | PERGPSPRPPATAYD CCCCCCCCCCCCCCC | 54.92 | 58859099 | |
| 209 | O-linked_Glycosylation | PSPRPPATAYDAPAS CCCCCCCCCCCCCHH | 31.37 | 31492838 | |
| 209 | Phosphorylation | PSPRPPATAYDAPAS CCCCCCCCCCCCCHH | 31.37 | 25394399 | |
| 211 | Phosphorylation | PRPPATAYDAPASAF CCCCCCCCCCCHHHH | 14.32 | 21712546 | |
| 216 | Phosphorylation | TAYDAPASAFGSSLL CCCCCCHHHHCHHHH | 24.07 | 25106551 | |
| 220 | Phosphorylation | APASAFGSSLLGSGG CCHHHHCHHHHCCCC | 16.03 | 26356563 | |
| 221 | Phosphorylation | PASAFGSSLLGSGGS CHHHHCHHHHCCCCC | 28.17 | 26356563 | |
| 225 | Phosphorylation | FGSSLLGSGGSAFAP HCHHHHCCCCCCCCC | 39.69 | 26356563 | |
| 228 | Phosphorylation | SLLGSGGSAFAPPLR HHHCCCCCCCCCCCC | 24.60 | 26356563 | |
| 235 | Methylation | SAFAPPLRAQDDLTL CCCCCCCCCCCCCCC | 35.66 | 58859115 | |
| 241 | Phosphorylation | LRAQDDLTLRRRPPK CCCCCCCCCCCCCCC | 25.80 | 18212344 | |
| 243 | Methylation | AQDDLTLRRRPPKAW CCCCCCCCCCCCCCC | 27.59 | 58859123 | |
| 253 | Phosphorylation | PPKAWNESDLDVAYE CCCCCCHHHCCCCCC | 40.02 | 28555341 | |
| 259 | Phosphorylation | ESDLDVAYEKKPSQT HHHCCCCCCCCCCCC | 28.29 | 25394399 | |
| 264 | Phosphorylation | VAYEKKPSQTASYER CCCCCCCCCCCCEEE | 49.39 | 30576142 | |
| 266 | Phosphorylation | YEKKPSQTASYERLD CCCCCCCCCCEEEEE | 23.16 | 26356563 | |
| 268 | Phosphorylation | KKPSQTASYERLDVF CCCCCCCCEEEEEEE | 30.80 | 30576142 | |
| 269 | Phosphorylation | KPSQTASYERLDVFA CCCCCCCEEEEEEEC | 11.56 | 27259358 | |
| 280 | Phosphorylation | DVFARPASPSLQLLP EEECCCCCCCCCCCC | 20.08 | 25159151 | |
| 282 | Phosphorylation | FARPASPSLQLLPWR ECCCCCCCCCCCCCC | 26.67 | 25159151 | |
| 291 | Phosphorylation | QLLPWRESSLDGLGG CCCCCCHHCCCCCCC | 27.85 | 23403867 | |
| 292 | Phosphorylation | LLPWRESSLDGLGGT CCCCCHHCCCCCCCC | 26.23 | 27794612 | |
| 299 | Phosphorylation | SLDGLGGTGKDNLTS CCCCCCCCCCCCCCC | 38.98 | 23403867 | |
| 301 | Ubiquitination | DGLGGTGKDNLTSAT CCCCCCCCCCCCCCC | 43.19 | - | |
| 305 | Phosphorylation | GTGKDNLTSATLPRN CCCCCCCCCCCCCCC | 23.67 | 29255136 | |
| 306 | Phosphorylation | TGKDNLTSATLPRNY CCCCCCCCCCCCCCC | 23.56 | 29255136 | |
| 308 | Phosphorylation | KDNLTSATLPRNYKV CCCCCCCCCCCCCCC | 36.74 | 29255136 | |
| 313 | Phosphorylation | SATLPRNYKVSPLAS CCCCCCCCCCCCCCC | 17.66 | 23403867 | |
| 314 | Methylation | ATLPRNYKVSPLASD CCCCCCCCCCCCCCC | 39.52 | 115975571 | |
| 314 | Ubiquitination | ATLPRNYKVSPLASD CCCCCCCCCCCCCCC | 39.52 | - | |
| 316 | Phosphorylation | LPRNYKVSPLASDRR CCCCCCCCCCCCCCC | 15.28 | 25159151 | |
| 320 | Phosphorylation | YKVSPLASDRRSDAG CCCCCCCCCCCCCCC | 39.06 | 29255136 | |
| 324 | Phosphorylation | PLASDRRSDAGSYRR CCCCCCCCCCCCHHH | 32.48 | 28555341 | |
| 328 | Phosphorylation | DRRSDAGSYRRSLGS CCCCCCCCHHHHCCC | 19.72 | 28555341 | |
| 332 | Phosphorylation | DAGSYRRSLGSAGPS CCCCHHHHCCCCCCC | 28.25 | 22167270 | |
| 335 | Phosphorylation | SYRRSLGSAGPSGTL CHHHHCCCCCCCCCC | 35.03 | 22167270 | |
| 339 | Phosphorylation | SLGSAGPSGTLPRSW HCCCCCCCCCCCCCC | 43.42 | 22617229 | |
| 341 | Phosphorylation | GSAGPSGTLPRSWQP CCCCCCCCCCCCCCC | 37.62 | 25159151 | |
| 344 | Methylation | GPSGTLPRSWQPVSR CCCCCCCCCCCCCCC | 54.35 | 82797337 | |
| 345 | Phosphorylation | PSGTLPRSWQPVSRI CCCCCCCCCCCCCCC | 28.29 | 29759185 | |
| 350 | Phosphorylation | PRSWQPVSRIPMPPS CCCCCCCCCCCCCCC | 31.04 | 29759185 | |
| 357 | Phosphorylation | SRIPMPPSSPQPRGA CCCCCCCCCCCCCCC | 49.10 | 30266825 | |
| 358 | Phosphorylation | RIPMPPSSPQPRGAP CCCCCCCCCCCCCCC | 33.07 | 30266825 | |
| 362 | Methylation | PPSSPQPRGAPRQRP CCCCCCCCCCCCCCC | 48.97 | 82796411 | |
| 373 | Phosphorylation | RQRPIPLSMIFKLQN CCCCCCHHHHHHHHH | 12.41 | 28555341 | |
| 395 | Phosphorylation | SRAMLPGSPLFTRAP CCCCCCCCCCCCCCC | 19.25 | 22167270 | |
| 399 | Phosphorylation | LPGSPLFTRAPPPKL CCCCCCCCCCCCCCC | 33.34 | 23403867 | |
| 400 | Methylation | PGSPLFTRAPPPKLQ CCCCCCCCCCCCCCC | 37.45 | 54558227 | |
| 489 | Phosphorylation | GPVARPLSPTRLQPA CCCCCCCCCCCCCCC | 27.23 | 24505115 | |
| 491 | Phosphorylation | VARPLSPTRLQPALP CCCCCCCCCCCCCCC | 40.41 | 23312004 | |
| 522 | Methylation | AEIPRPLKRRGSMEQ HHCCCCHHHCCCHHH | 42.61 | 115975579 | |
| 522 | Ubiquitination | AEIPRPLKRRGSMEQ HHCCCCHHHCCCHHH | 42.61 | - | |
| 526 | Phosphorylation | RPLKRRGSMEQAPAV CCHHHCCCHHHCCCC | 19.82 | 30266825 | |
| 538 | Phosphorylation | PAVALPPTHKKQYQQ CCCCCCCCCHHHHHH | 44.37 | 20068231 | |
| 541 | Ubiquitination | ALPPTHKKQYQQIIS CCCCCCHHHHHHHHH | 46.78 | 2189047 | |
| 541 (in isoform 1) | Ubiquitination | - | 46.78 | 21890473 | |
| 543 | Phosphorylation | PPTHKKQYQQIISRL CCCCHHHHHHHHHHH | 15.97 | 27642862 | |
| 567 | Phosphorylation | GGPEPELSPITEGSE CCCCCCCCCCCCCCC | 16.76 | 25159151 | |
| 570 | Phosphorylation | EPELSPITEGSEARA CCCCCCCCCCCCCCC | 37.36 | 23927012 | |
| 573 | Phosphorylation | LSPITEGSEARAGPP CCCCCCCCCCCCCCC | 23.11 | 20873877 | |
| 594 | Phosphorylation | PIPPPAPSQSSPPEQ CCCCCCCCCCCCCCC | 44.81 | 21712546 | |
| 596 | Phosphorylation | PPPAPSQSSPPEQPQ CCCCCCCCCCCCCCC | 49.50 | 23663014 | |
| 597 | Phosphorylation | PPAPSQSSPPEQPQS CCCCCCCCCCCCCCC | 36.52 | 21712546 | |
| 604 | Phosphorylation | SPPEQPQSMEMRSVL CCCCCCCCHHHHHHH | 24.32 | 22199227 | |
| 616 | Phosphorylation | SVLRKAGSPRKARRA HHHHHCCCHHHHHHH | 26.79 | 26853621 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IASPP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IASPP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TF65_HUMAN | RELA | physical | 12134007 | |
| SP1_HUMAN | SP1 | physical | 12134007 | |
| TF65_HUMAN | RELA | physical | 10336463 | |
| P53_HUMAN | TP53 | physical | 20840860 | |
| EP300_HUMAN | EP300 | physical | 21513714 | |
| P53_HUMAN | TP53 | physical | 21513714 | |
| P53_HUMAN | TP53 | physical | 17906639 | |
| CBP_HUMAN | CREBBP | physical | 25675294 | |
| EP300_HUMAN | EP300 | physical | 25675294 | |
| NF2L2_HUMAN | NFE2L2 | physical | 29033244 | |
| KEAP1_HUMAN | KEAP1 | physical | 29033244 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-70; SER-183 AND SER-187,AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102; SER-110; SER-113;SER-119; SER-120; THR-123; SER-134; SER-158; SER-183; SER-187;SER-203; SER-225; SER-316; SER-332; SER-526; SER-567 AND SER-597, ANDMASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-567, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110; SER-113; SER-183AND SER-187, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-567, AND MASSSPECTROMETRY. | |